Global Singleplex Immunoassay Market Growth (Status and Outlook) 2024-2030

Global Singleplex Immunoassay Market Growth (Status and Outlook) 2024-2030

Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification.

The global Singleplex Immunoassay market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Singleplex Immunoassay Industry Forecast” looks at past sales and reviews total world Singleplex Immunoassay sales in 2023, providing a comprehensive analysis by region and market sector of projected Singleplex Immunoassay sales for 2024 through 2030. With Singleplex Immunoassay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Singleplex Immunoassay industry.

This Insight Report provides a comprehensive analysis of the global Singleplex Immunoassay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Singleplex Immunoassay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Singleplex Immunoassay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Singleplex Immunoassay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Singleplex Immunoassay.

The Americas is expected to dominate the singleplex immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Singleplex Immunoassay market by product type, application, key players and key regions and countries.

Segmentation by type
Protein-Based Assays
Nucleic Acid Based Assays
Cell-Based Assays
Others

Segmentation by application
Hospitals & Research Institutes
Reference Laboratories
Pharmaceutical & Biotechnology Companies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad
Qiagen
Abcam
BD
Merck
Agilent Technologies
Quanterix
Bio-Techne
Olink
Seegene
BioVendor

Please note: The report will take approximately 2 business days to prepare and deliver.